HSTAX
Price
$103.43
Change
+$0.55 (+0.53%)
Updated
Jun 6 closing price
Net Assets
1.24B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

HSTAX vs VITSX

Header iconHSTAX vs VITSX Comparison
Open Charts HSTAX vs VITSXBanner chart's image
Hartford Stock HLS IA
Price$103.43
Change+$0.55 (+0.53%)
VolumeN/A
Net Assets1.24B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
HSTAX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HSTAX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSTAX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. HSTAX (1.24B). HSTAX pays higher dividends than VITSX: HSTAX (1.56) vs VITSX (1.29). HSTAX was incepted earlier than VITSX: HSTAX (48 years) vs VITSX (28 years). HSTAX (0.51) is less costly to investors than VITSX (0.03). HSTAX is a more actively managed with annual turnover of: 16.00 vs. VITSX (2.00). HSTAX has a lower initial minimum investment than VITSX: HSTAX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. HSTAX (2.57). VITSX return over 5 years is better than : 80.96 vs. HSTAX (22.01).
HSTAXVITSXHSTAX / VITSX
Total Expense Ratio0.510.031,700%
Annual Report Gross Expense Ratio0.510.031,700%
Fund Existence48 years28 years-
Gain YTD2.3680.833284%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B1.82T0%
Annual Yield % from dividends1.561.29121%
Returns for 1 year2.5710.9723%
Returns for 3 years0.0440.350%
Returns for 5 years22.0180.9627%
Returns for 10 years89.66180.4950%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.